Fibrocytes in rheumatoid pannus: Seed and soil?


  • Richard Bucala

    Corresponding author
    1. Yale University School of Medicine, New Haven, Connecticut
    • Department of Medicine, Section of Rheumatology, The Anlyan Center, S521, Yale University School of Medicine, 300 Cedar Street, New Haven, CT 06520
    Search for more papers by this author
    • Dr. Bucala has received honoraria for service on the Scientific Advisory Board of Promedior (less than $10,000) and owns stock or stock options in the company. Promedior is developing recombinant pentraxin to inhibit fibrocytes.

No abstract is available for this article.